Co-authors

Researcher identifiers

Export Publications

Export the displayed publications:
Number of documents

9

Olivier Colliot - Research Director at CNRS - ARAMIS Lab (CNRS/INRIA/Inserm/UPMC)


Research Director at CNRS

 

Head of the ARAMIS Lab, a joint team between CNRSInriaInserm and University Pierre and Marie Curie at the Brain and Spine Institute (ICM), in co-direction with Didier Dormont.

 


"Alexis Brice"   

Journal articles6 documents

  • Clémence Fournier, Mathieu Barbier, Agnès Camuzat, Vincent Anquetil, Serena Lattante, et al.. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers. Neurobiology of Aging, Elsevier, 2019, 74, pp.234.e1-234.e8. ⟨10.1016/j.neurobiolaging.2018.09.010⟩. ⟨hal-02025976⟩
  • Anne Bertrand, Junhao Wen, Daisy Rinaldi, Marion Houot, Sabrina Sayah, et al.. Early cognitive, structural and microstructural changes in c9orf72 presymptomatic carriers before 40 years of age. JAMA neurology, American Medical Association (imprimé) / 2018, 75 (2), pp.236-245. ⟨10.1001/jamaneurol.2017.4266⟩. ⟨hal-01654000⟩
  • Fatima Ameur, Olivier Colliot, Paola Caroppo, Sebastian Stroer, Didier Dormont, et al.. White matter lesions in FTLD: distinct phenotypes characterize GRN and C9ORF72 mutations. Neurology: Genetics, American Academy of neurology, 2016, 2 (1), ⟨10.1212/NXG.0000000000000047⟩. ⟨hal-01266596⟩
  • Paola Caroppo, Marie-Odile Habert, Stanley Durrleman, Aurélie Funkiewiez, Vincent Perlbarg, et al.. Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?. Journal of Alzheimer's Disease, IOS Press, 2015, 47 (3), pp.751-9. ⟨10.3233/JAD-150270⟩. ⟨hal-01220380⟩
  • Paola Caroppo, Isabelle Le Ber, Agnès Camuzat, Fabienne Clot, Lionel Naccache, et al.. Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin. JAMA neurology, American Medical Association (imprimé) / 2014, 71 (12), pp.1562-6. ⟨hal-01439037⟩
  • Harald Hampel, Simone Lista, Stefan J Teipel, Francesco Garaci, Robert Nisticò, et al.. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. Biochemical Pharmacology, Elsevier, 2014, pp.426-49. ⟨hal-01098832⟩

Conference papers3 documents

  • Anne Bertrand, Fatima Ameur, Paola Caroppo, Didier Dormont, Alexis Brice, et al.. Genetic Frontotemporal Dementia with TDP-43 Inclusions:Distinct Radiological Phenotypes between Patients with PGRN and C9ORF72 Mutations. RSNA, Nov 2014, Chicago, United States. ⟨hal-01439623⟩
  • Anne Bertrand, Fatima Ameur, Paola Caroppo, Didier Dormont, Alexis Brice, et al.. Incidence and characterization of supratentorial FLAIR hyperintenstities in patients with sporadic and genetic frontotemporal dementia. AAIC 2014 - Alzheimer’s Association International Conference, Jul 2014, Copenhagen, Denmark. ⟨hal-01114135⟩
  • Paola Caroppo, Marie-Odile Habert, Stanley Durrleman, Hugo Bertin, Alexandre Routier, et al.. Multimodal neuroimaging study in presymptomatic GRN mutations carriers. 9th International Conference on Frontotemporal Dementias (ICFTD), Oct 2014, Vancouver, Canada. ⟨hal-01114134⟩